|
|
Nephropathy
|
|
Nephropathy
[an error occurred while processing this directive]
Empiricus: our clinical journal commentator 24 Nov 2005
The first trial of a drug called ruboxistaurin in patients with diabetic nephropathy has shown a reduction in albuminuria and stabilisation of declining kidney ...
- AustralianDoctor.com (subscription),
SPP301 Phase IIb Results in Diabetic Nephropathy Presented at ASN Nov 11, 2005
12 /PRNewswire-FirstCall/ -- Speedel (SWX: SPPN) announced today that positive Phase IIb results of SPP301 in diabetic nephropathy (diabetic kidney disease ...
- PR Newswire (press release),
Vitamins and Minerals Can Help in Diabetic Nephropathy Oct 24, 2005
Beheshti University of Medical Sciences, Tehran and colleagues note that studies indicate that antioxidants can be helpful in diabetic nephropathy and there is ...
- About - News & Issues,
Keryx Announces Positive Final Results from Phase 2 Clinical Study ... Nov 11, 2005
An exploratory, randomized, double-blind, multiple dose study of KRX-101 (sulodexide gelcaps) for the treatment of type 2 diabetic nephropathy patients with ...
- PR Newswire (press release),
CuraGen Presents Phase I Results on CR002 at ASN Renal Week 2005 Nov 14, 2005
...clinical development to explore its role in potentially helping patients with kidney inflammation caused by PDGF-D, including IgA nephropathy and diabetic ...
- PR Newswire (press release),
Keryx Biopharmaceuticals, Inc, Announces Final Phase II Data ... Oct 24, 2005
Collaborative Study Group, will be presenting final data from the Company's Phase II study of KRX-101 (oral sulodexide gelcap) for diabetic nephropathy at the ...
- PR Newswire (press release),
SPP301 Phase IIb Data to Be Presented at American Society of ... Oct 27, 2005
28 /PRNewswire/ -- Speedel (SWX: SPPN) announced today that data from its Phase IIb study of SPP301 in the treatment of diabetic nephropathy will be presented ...
- PR Newswire (press release),
Evidence Supports First Non-Injectable Insulin as Alternative ... Nov 21, 2005
...therapy over the course of their disease to control blood glucose and avoid serious complications including cardiovascular disease, neuropathy, and nephropathy ...
- Newswise (press release)
SPP301 Phase IIb Data to Be Presented at American Society of ... Oct 28, 2005
NJ, October 28, 2005 /PRNewswire/ -- Speedel announced today that data from its Phase IIb study of SPP301 in the treatment of diabetic nephropathy will be ...
- PharmaLive.com (press release),
AHA: Actos More Effective in Patients with Recent Heart Attacks Nov 16, 2005
At baseline, 75.4% of patients had hypertension, 57.5% angina, 23.6% claudication, 23.2% retinopathy, 14.1% nephropathy, and 5.7% had a history of transient ...
- MedPage Today,
NicOx announces presentation of NCX 4016 phase 2a results in type ... Nov 16, 2005
NICOX) announced today that the results of a 13-patient, exploratory phase 2a study in patients with type 2 diabetes and early nephropathy were reported ...
- Biotech Intelligence (press release),
Results of the largest clinical trial in type 2 diabetes patients ... Nov 14, 2005
Moreover, few patients at baseline suffered from retinopathy (8%) or nephropathy (3%). About one-third (38%) of patients had both triglyceride concentrations ...
- Medical News Today (press release),
Drugs in Developement Nov 15, 2005
...(kyorin.co.jp). Diabetic neuropathy is one of three major diabetic complications along with retinopathy and nephropathy. Symptoms ...
- R&D Directions (subscription),
FlowMedica Inc., Completes $15 Million Series D Financing Nov 8, 2005
Physicians are assessing these systems in patients at risk for two major conditions that can cause kidney dysfunction: Radiocontrast nephropathy (RCN), one of ...
- Business Wire (press release),
FibroGen Appoints Russell H. Ellison, MD, MSc, Vice President of ... Nov 10, 2005
...will focus on expansion of the Company's clinical development team and rapid advancement of key clinical programs in anemia, diabetic nephropathy, and dermal ...
- PharmaLive.com (press release),
Renal Week Debates on Drugs and the Kidney Nov 12, 2005
Participants include Monique M. Elseviers, PhD, University Antwerp, Wilrijk, Antwerp, Belgium (“Epidemiology of Analgesic Nephropathy 2005�); Marc E. De ...
- Newswise (press release)
"Share the Care" and help improve another's life Nov 10, 2005
Over about 8 years the cardiovascular risk was decreased 53%; nephropathy (kidney) risk decreased 61%; retinopathy (eye) risk decreased 58%; and autonomic ...
- Hope Standard,
Low-Dose Epoetin Beta Offers Improved Renal Anaemia Management for ... Nov 11, 2005
...pressure. Diabetic nephropathy (22.9%) and glomerulonephritis (27.0%) were the top two reasons for patients requiring haemodialysis. ...
- DG News
Academia, industry join forces to honour world-renowned Canadian ... Nov 15, 2005
...“We are in the midst of a pandemic of diabetic nephropathy and we are going to see an increasing number of these patients with end-stage renal disease ...
- News@UofT,
Keryx Biopharmaceuticals to Present at Bear Stearns SMid-Cap ... Nov 4, 2005
Keryx's lead compound under development is KRX-101 (sulodexide), a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life ...
- PR Newswire (press release),
Anthrax treatment may be deadly Oct 27, 2005
..."Evidence suggests that this likely clogged the renal tubules, causing an acute toxic nephropathy (acute tubular necrosis) that was seen on necropsy in the ...
- United Press International
Neuropsychiatric effects of caffeine Nov 1, 2005
2003). Excessive use of caffeine-containing analgesics has been linked to analgesic nephropathy (De Broe et al, 2003). Caffeine ...
- Adv Psychiatric Treat (subscription)
Hypertension and Diabetic Kidney Disease - Prevalence, current ... Oct 24, 2005
The commercial potential for successful new agents is substantial as existing therapies do not halt the progression of diabetic nephropathy to end stage renal ...
- Pharmaceutical Business Review
Pathogenesis of Contrast-Induced Nephropathy Sep 24, 2005
...activation of tubuloglomerular feedback by osmotic diuresis induced by contrast media is a common hypothesis for the development of contrast nephropathy. ...
- Am J Roentgenology (subscription)
Viral Load and HIV-Associated Nephropathy Sep 7, 2005
To the Editor: Most often, nephropathy associated with human immunodeficiency virus type 1 (HIV-1) occurs after years of HIV-1 infection, although occasional ...
- New England Journal of Medicine (subscription)
Experimental membranous nephropathy redux Sep 17, 2005
Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. Active and passive Heymann nephritis (HN) in rats ...
- AJP-Renal Physiology
Drugs in Development Sep 21, 2005
...has started a Phase III study of SPP301, a once-a-day oral endothelin A receptor antagonist in the indication of diabetic nephropathy. ...
- R&D Directions (subscription)
Eisai Signs In-Licensing Agreement with Dainippon Pharmaceutical ... Sep 29, 2005
...other countries. Diabetic neuropathy is one of three major diabetic complications along with retinopathy and nephropathy. Patients ...
- PharmaLive.com (press release)
On a quest for a kidney Sep 29, 2005
...blood pressure. He and his wife Kim, who live near Foxhome, were told Loren has a rare kidney disease called IgA nephropathy. He ...
- Fergus Falls Daily Journal
Pilot Study of Ruboxistaurin Showed Favorable Effects on Kidney ... Sep 12, 2005
Athens, Greece (ots/PRNewswire) - - Approximately 40 percent of people with diabetes develop nephropathy, the leading cause of kidney failure Eli Lilly and ...
- news aktuell (Pressemitteilung)
Autoimmune Kidney Disease Sep 4, 2005
This is true for IgA nephropathy. ... IgA nephropathy is a form of glomerulonephritis. Damage is caused in the kidney by the abnormal buildup of a protein (IgA). ...
- rarediseases.about.com
Cyclacel Announces Collaboration on Nephrology Applications of CDK ... Sep 14, 2005
CDK inhibition in preclinical models of renal disease including lupus nephritis, crescentic glomerulonephritis, HIV associated nephropathy and IgA nephropathy. ...
- PharmaLive.com (press release)
Pilot Study of Ruboxistaurin Showed Favorable Effects on Kidney ... Sep 12, 2005
...a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy ...
- PR Newswire UK (press release)
GM animals aid in research to benefit kids Sep 21, 2005
They said recent use of genetically engineered mice and rats in combination with an animal model of obstructive nephropathy -- a type of renal disease - has ...
- Science Daily (press release)
Genetically Engineered Animals Help In Scientific Research That ... Sep 22, 2005
21, 2005 - The recent use of genetically modified mice and rats in combination with an animal model of obstructive nephropathy, a type of renal disease, has ...
- Science Daily (press release)
HURRICANE RITA BRINGS EAST TEXAN 2nd CHANCE AT LIFE Sep 29, 2005
...blessed," Ms. Caffee said. Meadows, who has a condition called IgA nephropathy, said he's grateful for the kidney. He was upset ...
- Tyler Morning Telegraph
King Pharmaceuticals Reports FDA Acceptance of Altace(R) ... Sep 22, 2005
...clinical trials: the AASK (African American Study of Kidney Disease and Hypertension) trial(1) and the REIN (Ramipril Efficacy In Nephropathy) trial.(2,3) The ...
- PR Newswire (press release)
King Pharmaceuticals Reports FDA Acceptance of Altace® Sep 27, 2005
...two, randomized clinical trials: AASK (African American Study of Kidney Disease and Hypertension) trial and the REIN (Ramipril Efficacy In Nephropathy) trial.
- Business Journal of Tri Cities
Venus launches new drug for treating respiratory diseases Sep 20, 2005
...drug is considered ideal for ICU, AIDS, cancer, angina pectoris and MI patients as it is a potent detoxifier and prevents radio contrast induced nephropathy. ...
- Hindu Business Line
Venus launches new drug Sep 20, 2005
...drug is considered ideal for ICU, AIDS, Cancer, Angina Pectoris and MI patients as it's a potent de-toxifier and prevents radio contrast induced nephropathy. ...
- Economic Times
Younger Parise has spot in some hearts already Sep 15, 2005
Defenseman David Hale, who has endured recurring bouts of the kidney ailment IgA nephropathy, including one which sidelined him for much of last season with ...
- Newark Star Ledger
Keryx to Present at Oppenheimer Diabetes Conference, Tomorrow ... Sep 6, 2005
...the Company's lead compound under development, is currently being evaluated in a Phase III/IV clinical program for the treatment of diabetic nephropathy. ...
- PR Newswire (press release)
CME programme on diabetes Sep 17, 2005
Department of Nephrology associate professor Dr Ramachandra, in his guest lecture on ‘‘recent advances in diabetic nephropathy’’ elaborated that ...
- Newindpress
FDA Approves New Drug Application for Chronic Kidney Disease Sep 22, 2005
...randomized clinical trials: the AASK (African American Study of Kidney Disease and Hypertension) trial(1) and the REIN (Ramipril Efficacy In Nephropathy) trial ...
- AXcess News
Landmark Study Shows Takeda's Actos(R) (Pioglitazone) Reduces ... Sep 12, 2005
...studies have shown that by intensively controlling hyperglycaemia, the incidence of microvascular complications (such as retinopathy, nephropathy and neuropathy ...
- PR Newswire UK (press release)
Devils' Elias on slow road to recovery Sep 14, 2005
Hale battled IgA nephropathy, a disease that affects the kidneys, during college. . . . Training camp officially opens this morning at Codey Arena.
- Asbury Park Press
EASD: Actos Benefits Heart Attack Survivors with Type 2 Diabetes Sep 13, 2005
At baseline, 75.4% of patients had hypertension, 57.5% angina, 23.6% claudication, 23.2% retinopathy, 14.1% nephropathy, and 5.7% had a history of transient ...
- MedPage Today
Keryx to Present at the Bear Stearns 18th Annual Healthcare ... Sep 9, 2005
Keryx' lead compound under development is KRX-101 (sulodexide), a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life ...
- PR Newswire (press release)
Office to tackle the bureaucrats' gobbledygook Sep 12, 2005
When warned that painkillers might cause "analgetica nephropathy", most of us haven'ta clue what it means. That's where the bureau comes in handy. ...
- Expatica
New Type of Hypertension Treatment Effective and Well Tolerated Sep 3, 2005
...therapy and in phase II as combination therapy in patients with mild-to-moderate hypertension, and in phase II trials in patients with diabetic nephropathy. ...
- I-Newswire.com (press release)
Advanced glycation end products and the kidney Sep 30, 2005
These effects are most prominent in diabetic nephropathy, but they also contribute to renal pathophysiology in other nondiabetic renal diseases. ...
- AJP-Renal Physiology
Speedel Gains Stock Listing In Zurich But Raises No Cash Sep 13, 2005
Speedel itself moved SPP301, an endothelin receptor antagonist, into a pivotal Phase III trial in diabetic nephropathy in July. ...
- BioWorld Online (subscription)
Managing your kidneys31 Jul 2005
...for Your Kidneys (Fit For Life, July 17, 2005), we stressed the importance of good diabetes management to prevent diabetic kidney disease (diabetic nephropathy ...
- Malaysia Star
Establishment of a Diabetic Mouse Model with Progressive Diabetic ...Jul 27, 2005
...mice that overexpress inducible cAMP early repressor (ICER I ) in pancreatic ß cells are a good model to study the pathogenesis of diabetic nephropathy. ...
- Am J Pathology (subscription)
Speedel Starts Phase III Study of SPP301 in Diabetic NephropathyJul 6, 2005
...start of its Phase III study for SPP301, its once-a-day oral endothelin A receptor antagonist (ERA) in the indication of diabetic nephropathy (diabetic kidney ...
- Yahoo News
Peripheral Total and Differential Leukocyte Count in Diabetic ...Jul 9, 2005
...of diabetes complications, this study aimed to investigate the relation of circulating total and differential leukocyte counts to nephropathy in patients with ...
- RedNova.com
Speedel Begins Pivotal Trial Of SPP301 In Diabetic NephropathyJul 12, 2005
Four months after reporting positive results from a Phase IIb trial of its endothelin A receptor antagonist, SPP301, in diabetic nephropathy, Speedel Group AG ...
- BioWorld Online (subscription)
Investigations for Diabetes MellitusJul 29, 2005
MAU as the name suggests, is the first warning signal to an impending “Nephropathy� - if attention is not paid to keep diabetes under control. ...
- Express Healthcare Management
The Broadening Domain of the Metabolic SyndromeJul 29, 2005
In addition, the prevalence of overt nephropathy and proliferative retinopathy was significantly higher in patients with features of the metabolic syndrome. ...
- Medscape (subscription)
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second ...Jul 29, 2005
Keryx's lead compound under development is KRX-101 (sulodexide), a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life ...
- PrimeZone
Actelion announces Half Year financial results 2005Jul 29, 2005
...data generated in the proof-of-concept program, testing its urotensin-II receptor antagonist, palosuran, in the indication diabetic nephropathy did not support ...
- PharmaLive.com
HemoCue Introduces a Point-of-Care Urine Albumin System for ...Jul 25, 2005
Microalbuminuria is a powerful predictor for the future development of diabetic nephropathy and cardiovascular disease. Diabetic ...
- Yahoo News
NicOx reports first-half 2005 financial results and provides aJul 27, 2005
Results are expected from a phase II trial for NCX 4016 in patients with type II diabetes and early nephropathy in the second half of 2005 and NicOx is working ...
- Companynewsgroup (Comunicados de prensa)
Region-Specific Alterations of Adenosine Receptors Expression ...Jul 27, 2005
...and tissue distribution, correspond to abnormalities characteristic of the diabetic kidney, suggesting involvement in pathogenesis of diabetic nephropathy.
- Am J Pathology (subscription)
Your Weekly Review of Key GP Guidance From MIMSJul 29, 2005
2 diabetes. Microalbuminuria is the earliest indicator of renal disease (nephropathy) attributable to diabetes. Microalbuminuria ...
- RedNova.com
Soy is good for your kidneys and heartJul 19, 2005
Diabetic nephropathy is kidney disease that develops as a result of diabetes and is the primary cause of chronic renal failure in the United States and other ...
- Health Sentinel
Increased Demand For Astaxanthin to be Met By Fuji Health Science ...Jul 25, 2005
In addition, the company supports ongoing research on the health benefits of astaxanthin in such areas as eye fatigue and diabetic nephropathy.
- NPIcenter
Noninvasive Diagnosis of Coronary Artery Disease in Patients With ...Jul 9, 2005
...than two risk factors for CAD, had normal baseline electrocardiogram and no history of stroke, or had peripheral vascular disease, nephropathy, neuropathy, or ...
- RedNova.com
Vital functionJul 10, 2005
Common causes of ESRD in children are glomerulonephritis (54%) and reflux nephropathy (7%). Glomerulonephritis is caused by inflammation of the internal kidney ...
- Malaysia Star
Care for your kidneysJul 16, 2005
Diabetes mellitus, coupled with high blood pressure and cigarette smoking, is the leading cause of kidney disease (diabetic nephropathy) in many countries. ...
- Malaysia Star
Tight Glucose Control Lowers Heart RisksJul 7, 2005
...of blood glucose levels in people with Type 1 diabetes lowered the risk of retinopathy (eye disease), neuropathy (nerve damage), and nephropathy (kidney disease ...
- Diabetes Self Management
Avandia: decreased HDL cholesterol levelsJul 17, 2005
A 61-year-old woman with type 2 diabetes, hyperlipidemia, diabetic retinopathy and nephropathy had been taking Fenofibrate, Metformin and Glyburide for more ...
- Xagena.it
Keryx plans to raise $70mJul 12, 2005
18%. Keryx’s flagship product, KRX-101 (Sulodexide), is an oral treatment for diabetic nephropathy, a kidney disease. Another ...
- Globes Online
Hematuria in Children: When to WorryJul 1, 2005
The common causes of gross hematuria included hypercalciuria (51), IgA nephropathy (34), and post-streptococcal glomerulonephritis (21). ...
- AAP Grand Rounds (subscription)
HaptoGuard Announces Peer-Review Publication Supporting Gene ...Jul 12, 2005
...shown by HaptoGuard's collaborators, the Hp 2 genotype is an independent risk factor for diabetic vascular diseases, including nephropathy, retinopathy and ...
- Yahoo News
Gastrointestinal Stem Cells I. Pancreatic stem cellsJul 13, 2005
These complications include retinopathy, nephropathy, neuropathy, arteriosclerosis, and heart disease along with a considerable reduction of the quality and ...
- AJP-Gastrointestinal & Liver Physiology (subscription)
Before the BureauJul 1, 2005
By 2030, there will be about 370 million people worldwide with type 2 diabetes and approximately one-third of them will develop nephropathy and require ...
- INQ7 Interactive, Inc.
Endocrinology & Metabolism News, July 2005Jul 6, 2005
Pancreas transplant, by restoring sustained normoglycemia, improved diabetic nephropathy (Diabetes Care (June 2005) 28:1366) and retinopathy (Transpl Int (May ...
- Journal of Clinical Endocrinology and Metabolism
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Nephropathy
you may want to try searching the Internet using the Google search box below.
|
|
|
